Philipp Mathieu

Philipp Mathieu is a seasoned healthcare executive with two decades of leadership and investment experience in both European and US markets. Currently serving as the Chief Financial Officer at AnaCardio AB, Philipp has previously held roles as CEO and President at Immunovia AB and as a healthcare investment banker at Lehman Brothers and Lazard. Additionally, Philipp is an advisor and investor at Octahedron Management AB and has experience as a portfolio manager and senior investment advisor at a large single-family office. Philipp earned a Diploma of Education in Economics from Georg-August-Universität Göttingen and a Master of Science in Finance with Distinction from Cass Business School.